Clinical Trial Update: Adjuvant Quisinostat in High-Risk Uveal Melanoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 adjuvant trial of quisinostat in high-risk uveal melanoma, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Quisinostat (quisinostat)

Snippet

Sponsor: University of Miami | Conditions: Uveal Melanoma | Phase 2 | Status: RECRUITING